Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kan Jang + curcumin
- Development stage
- Unknown
- Lead developer
- Swedish Herbal Institute
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Kan Jang + curcumin** is a combination of natural plant extracts being investigated for the treatment of the common cold and upper respiratory tract infections. Kan Jang is a well-established herbal medicinal product containing standardized extracts of *Andrographis paniculata* (SHA-10) and *Eleutherococcus senticosus* (SHE-3), originally developed by the Swedish Herbal Institute. Curcumin is a polyphenolic compound derived from turmeric (*Curcuma longa*) with potent anti-inflammatory and antioxidant properties. The combination is being evaluated by Procter & Gamble in a Phase 3 clinical trial (EudraCT 2005-005207-42) to assess its efficacy in reducing the severity and duration of cold symptoms compared to placebo, with an active control arm of ibuprofen plus chlorphenamine maleate.
- Other names
- Kan Jang plus curcuminKan Jang and curcumin
02
Targets
IKK complexNFKB1 (NF-κB1)EP300 (Histone acetyltransferase p300)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Kan Jang + curcumin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kan Jang + curcumin.